Sarah Jorczyk January 2, 2018 What Is The Difference Between Full Spectrum, Broad Spectrum, and Isolate CBD Oil? Understanding the difference between the three major types of CBD products (full spectrum vs broad spectrum vs isolate CBD oil) is one of the most important first steps on your CBD journey. Once you understand the difference…
Author: Kreisler
wsvn.com Can’t Live Without Prescription Pain Pills
Patrick Fraser | Ambar Rodriguez July 22, 2019 TO VIEW VIDEO GO TO “LINK TO ORIGINAL VIDEO” LISTED BELOW. (WSVN) – It’s a terrible way to live. Horrible pain that never stops. Pain medications help, but imagine being told the pain pills that keep you going will be cut off. Thousands of Americans are now facing that,…
Trump WH Seeks To Monitor The Disabled To Ensure They Aren’t “Too” Happy
https://mavenroundtable.io/theintellectualist/news/trump-wh-seeks-to-monitor-the-disabled-to-ensure-they-aren-t-too-happy-1GE1YTfza0KHKw1oGIOrYA/ A new policy proposal by the Trump administration calls for the surveillance of disabled people’s social media profiles to determine the necessity of their disability benefits. The proposal, which reportedly aims to cut down on the number of fraudulent disability claims would, monitor the profiles of disabled people and flag content that shows them…
Opioid expert: ‘I don’t really see’ the Trump administration doing a lot to help.
Adriana Belmonte Yahoo Finance, July 18, 2019, 7:27am PDT “GO TO ORIGINAL ARTICLE BELOW TO VIEW VIDEO.“ The opioid crisis is drawing attention from all sides. Fed Chair Jerome Powell even mentioned it during recent testimony to the House Financial Services Committee, speaking to how it’s affected labor force participation. Legislation to provide funding for drug abuse treatments has received bipartisan support,…
Opioid Labeling Bill Drawing Fire from Chronic Pain Advocates Posted on July 13, 2019 by Ed Coghlan
A bill introduced by West Virginia Democratic Senator and Indiana Republican Senator is drawing fire from chronic pain patient advocates. The bill they call The FDA Opioid Labeling Accuracy Act would “prohibit the Food and Drug Administration (FDA) from allowing opioids to be labeled for intended use of ‘around-the-clock, long-term opioid treatment’ until a study…

